The company is overhauling its Innovative Medicine supply chain, MedTech Surgery franchise, and Orthopaedics franchise, with total costs exceeding $2.4B.
Filing excerpt
In the fiscal second quarter of 2026, the Company initiated a supply chain restructuring program primarily in the Innovative Medicine segment to exit certain manufacturing locations as part of its optimization efforts to streamline operations. The program is expected to be substantially complete by the end of 2029 with estimated costs between $650 million and $750 million...
What this signalsFilings often name leadership changes, deals and spending plans.
sec-10qrestructuringChargeGet every 10-Q signal for Johnson & Johnson and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Johnson & Johnson this week?”
The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/95e713a4-cfbf-4333-8efc-b45aae03d753 returns this record as JSON. POST /v1/companies/enrich returns every signal for jnj.com.
{
"signal_id": "95e713a4-cfbf-4333-8efc-b45aae03d753",
"signal_type": "sec-10q",
"signal_subtype": "restructuringCharge",
"detected_at": "2026-07-28T07:04:43.812+00:00",
"company": {
"name": "Johnson & Johnson",
"domain": "jnj.com"
},
"data": {
"detail": "The company is overhauling its Innovative Medicine supply chain, MedTech Surgery franchise, and Orthopaedics franchise, with total costs exceeding $2.4B. This massive operational shift creates opportunities for vendors in logistics, consulting, and IT to support site closures, process optimization, and asset decommissioning.",
"metrics": {
"timeframe": "current_quarter",
"dollar_context": "Estimated cost for new Innovative Medicine supply chain restructuring program",
"dollar_millions": 750
},
"summary": "J&J initiates $750M supply chain restructuring, adding to $1.7B in ongoing programs",
"excerpts": "In the fiscal second quarter of 2026, the Company initiated a supply chain restructuring program primarily in the Innovative Medicine segment to exit certain manufacturing locations as part of its optimization efforts to streamline operations. The program is expected to be substantially complete by the end of 2029 with estimated costs between $650 million and $750 million...",
"relevance": 0.9,
"sentiment": "neutral",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/200406/000020040626000153/jnj-20260628.htm",
"filing_date": "2026-07-23",
"filing_year": 2026,
"fiscal_year": 0,
"fiscal_year_end": "06/28",
"sales_relevance": "Vendor review likely",
"signal_category": "financial"
}
}
curl https://signals.autobound.ai/v1/signals/95e713a4-cfbf-4333-8efc-b45aae03d753 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"jnj.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.